Deals
Search SEC
Investors
Sectors
Insights
Ask AI
Signal
Pricing
API
Sign In
Get Access
Deals
Search SEC
Investors
Sectors
Insights
Ask AI
Signal
Pricing
API
Sign In
Get Access
← All investors
Versant Ventures
2 portfolio companies · $8.2M tracked · Biotechnology, Public Equity (NASDAQ)
Portfolio companies
Tempest Therapeutics, Inc.
Private Placement
Biotechnology
· BRISBANE, CA
$7.5M
Signal 77
CRISPR THERAPEUTICS AG
Rule 144
Public Equity (NASDAQ)
· Zug, V8
$720K
Signal 61
Other investors
Y Combinator
General Catalyst
Insight Partners
T. Rowe Price
New Enterprise Associates
Goldman Sachs
Sequoia Capital
National Institutes of Health
Khosla Ventures
Accel